Researchers at MIT develop new nanoparticles that stimulate the immune system to attack ovarian tumors
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-Oct-2025 07:11 ET (31-Oct-2025 11:11 GMT/UTC)
MIT researchers designed nanoparticles that can deliver an immune-stimulating molecule called IL-12 directly to ovarian tumors. When given to mice along with checkpoint inhibitors, the treatment eliminated metastatic tumors more than 80 percent of the time.
Researchers characterize distinct immune environments in lymphoma, providing a new framework to engage the immune system in treating the disease
Study finds U.S. adults have widespread misperceptions of the cancer risks of alcohol
Scientists discover new target for pain hypersensitivity
Early clinical studies show encouraging results in kidney and prostate cancer